The Corona Study of Middle Norway

CompletedOBSERVATIONAL
Enrollment

223

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

August 12, 2022

Conditions
SARS-CoV-2 Acute Respiratory DiseaseSARS-CoV-2 SepsisSARS CoV 2 Infection
Interventions
OTHER

No intervention

No intervention, cohort study.

Trial Locations (5)

6017

Ålesund Hospital, Ålesund

6405

Molde Hospital, Molde

7006

St. Olavs Hospital, Trondheim

7600

Levanger Hospital, Levanger

7800

Namsos Hospital, Namsos

All Listed Sponsors
collaborator

The Research Council of Norway

OTHER

collaborator

Alesund Hospital

OTHER

collaborator

Namsos Hospital

OTHER

collaborator

Molde Hospital

OTHER

collaborator

Helse Nord-Trøndelag HF

OTHER

lead

St. Olavs Hospital

OTHER

NCT05638178 - The Corona Study of Middle Norway | Biotech Hunter | Biotech Hunter